RESUMO
BACKGROUND AND OBJECTIVES: Hepcidin is the main hormone that regulates iron balance. Its lowering favours digestive iron absorption in cases of iron deficiency or enhanced erythropoiesis. The careful dosage of this small peptide promises new diagnostic and therapeutic strategies. Its measurement is progressively being validated and now its clinical value must be explored in different physiological situations. Here, we evaluate hepcidin levels among premenopausal female donors with iron deficiency without anaemia. MATERIALS AND METHODS: In a preceding study, a 4-week oral iron treatment (80 mg/day) was administered in a randomized controlled trial (n = 145), in cases of iron deficiency without anaemia after a blood donation. We subsequently measured hepcidin at baseline and after 4 weeks of treatment, using mass spectrometry. RESULTS: Iron supplementation had a significant effect on plasma hepcidin compared to the placebo arm at 4 weeks [+0·29 nm [95% CI: 0·18 to 0·40]). There was a significant correlation between hepcidin and ferritin at baseline (R(2) = 0·121, P < 0·001) and after treatment (R(2) = 0·436, P < 0·001). Hepcidin levels at baseline were not predictive of concentration changes for ferritin or haemoglobin. However, hepcidin levels at 4 weeks were significantly higher (0·79 nm [95% CI: 0·53 to 1·05]) among ferritin responders. CONCLUSIONS: This study shows that a 4-week oral treatment of iron increased hepcidin blood concentrations in female blood donors with an initial ferritin concentration of less than 30 ng/ml. Apparently, hepcidin cannot serve as a predictor of response to iron treatment but might serve as a marker of the iron repletion needed for erythropoiesis.
Assuntos
Doadores de Sangue , Hepcidinas/sangue , Ferro da Dieta/administração & dosagem , Ferro/sangue , Administração Oral , Adolescente , Adulto , Biomarcadores/sangue , Feminino , Hemoglobinas/análise , Hepcidinas/efeitos dos fármacos , Humanos , Ferro/administração & dosagem , Ferro da Dieta/farmacologia , Pessoa de Meia-IdadeRESUMO
BACKGROUND AND OBJECTIVE: Restless legs syndrome (RLS) is a frequent condition with a prevalence of 5-15% in the general population. Clinical and genetic observations have shown that iron deficiency, highly prevalent among blood donors, can be related to RLS. The objective of this study was to assess the prevalence of RLS in female blood donors 1 week after blood donation. METHODS: One week after blood donation, 291 female blood donors, aged <50 years, self-responded to all four RLS questions defined by the 1995 International RLS study group. Blood donation rate, fatigue, aerobic capacity, menstruation, mood disorder and quality of life were also assessed along with haemoglobin and ferritin blood concentrations. RESULTS: Prevalence of RLS in female blood donors 1 week after blood donation was 6·9% (CI 95% 4·2-10·4%). Female blood donors with RLS had a higher prevalence of hyper-menorrhaea (P = 0·033) and were significantly more tired (P = 0·001). We observed no associations between RLS and number of previous donations (P = 0·409), aerobic capacity (P = 0·476), mood disorder (P = 0·169), quality of life (P = 0·356), haemoglobin (P = 0·087), and serum ferritin level (P = 0·446). CONCLUSION: Restless legs syndrome prevalence in female blood donors is not as important as described in some other studies, which could reassure blood donors. The prevalence of hypermenorrhaea and fatigue is higher in RLS blood donors. Therefore, screening for fatigue and hypermenorrhaea could be considered as these symptoms are associated with RLS in female blood donors.
Assuntos
Doadores de Sangue/estatística & dados numéricos , Síndrome das Pernas Inquietas/epidemiologia , Adulto , Análise de Variância , Anemia Ferropriva/etiologia , Anemia Ferropriva/terapia , Feminino , Ferritinas/sangue , Hemoglobinas/metabolismo , Humanos , Pessoa de Meia-Idade , PrevalênciaRESUMO
Iron deficiency is generally investigated when faced with anemia, or with symptoms that could be related to iron deficiency without anemia. This simple disorder is easy to treat, provided that the diagnosis is correct. Several biological tests are available, but their interpretation is oftentimes problematic. Pre-analytical factors can interfere with measurements, normal values can change depending on suppliers, and, above all, results from different markers can be contradictory in some clinical situations. The aim of this article is to evaluate how the evolution of scientific knowledge and clinical trials can contribute to a better understanding and greater reliability in the diagnosis of iron deficiency.
Assuntos
Anemia Ferropriva/diagnóstico , Ferritinas/sangue , Ferro/sangue , Oligoelementos/sangue , Transferrinas/sangue , Alelos , Anemia Ferropriva/sangue , Anemia Ferropriva/genética , Antibacterianos/sangue , Peptídeos Catiônicos Antimicrobianos/sangue , Biomarcadores/sangue , Ensaios Clínicos como Assunto , Diagnóstico Diferencial , Contagem de Eritrócitos , Índices de Eritrócitos , Hematócrito , Hemoglobinas/metabolismo , Hepcidinas , Humanos , Mutação , Contagem de Plaquetas , Polimorfismo de Nucleotídeo Único , Valor Preditivo dos Testes , Ensaios Clínicos Controlados Aleatórios como Assunto , Receptores da Transferrina/sangue , Receptores da Transferrina/genética , Sensibilidade e EspecificidadeRESUMO
Geophagia, eating of earth, is a relative frequent practice in several countries and especially in the African and South American mainlands. In some cases, migrant people continue this practice in the host country. Geophagia has some positive effects, presumed or real, and several harmful effects with significant health impacts. We relate the history of young patient of Cameroonian origin who consults for chonic fatigue, abdominal pain and menorrhagia. Laboratory tests show a severe aneamia with iron deficiency.
Assuntos
Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/etiologia , Compostos Férricos/uso terapêutico , Hematínicos/uso terapêutico , Pica/complicações , Dor Abdominal/etiologia , Adulto , Anemia Ferropriva/complicações , Anemia Ferropriva/diagnóstico , Camarões , Fadiga/etiologia , Feminino , Humanos , Injeções Intravenosas , Menorragia/etiologia , Pobreza , Fatores de Risco , Suíça , Resultado do TratamentoRESUMO
Vitamin B12 and iron deficiencies are common problems in consultations of general internal medicine. They cause different symptoms that can be non-specific. This article makes it possible, from a clinical frame of reference, to answer the following questions: What value of vitamin B12 should we consider a "deficiency", and what is the role of methylmalonate? What is the role of vitamin B12 oral supplements? How should we interpret values of ferritine? How should iron deficiency be investigated? What is the place of intravenous iron administration?
Assuntos
Anemia Ferropriva/diagnóstico , Anemia Ferropriva/terapia , Distrofia Simpática Reflexa/diagnóstico , Deficiência de Vitamina B 12/diagnóstico , Deficiência de Vitamina B 12/terapia , Anemia Ferropriva/complicações , Anemia Ferropriva/etiologia , Diagnóstico Diferencial , Feminino , Ferritinas/sangue , Ferritinas/deficiência , Ferritinas/fisiologia , Seguimentos , Humanos , Pessoa de Meia-Idade , Distrofia Simpática Reflexa/etiologia , Vitamina B 12/sangue , Vitamina B 12/uso terapêutico , Deficiência de Vitamina B 12/complicações , Deficiência de Vitamina B 12/etiologiaRESUMO
Should we treat iron deficiency without anemia? The simple fact that the question can be formulated already leads to controversies. During the past years, the development of a new formulation of intravenous iron has helped fuel the controversy. What is the situation in 2012? This article gives a practical point of view on the actual situation and provides indications on the use of new intravenous medications.
Assuntos
Desenho de Fármacos , Compostos de Ferro/uso terapêutico , Deficiências de Ferro , Anemia Ferropriva/tratamento farmacológico , Humanos , Infusões Intravenosas , Ferro/administração & dosagem , Compostos de Ferro/administração & dosagemRESUMO
Driving requires integrating multiple motor, sensory, and cognitive skills. As people age, cognition becomes increasingly vulnerable due to impairment and dementia. Older drivers suffering from dementia, even at an early stage, have been shown to be significantly more likely to develop unsafe driving. Primary care physicians have the difficult task to assess these persons' driving capacity. This paper briefly describes the consequences of altered cognition on driving capacity and proposes an algorithm to address this challenge.
Assuntos
Condução de Veículo , Demência/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Cognição , HumanosRESUMO
Giant cell arteritis (GCA) (or Horton's disease) is a systemic disease affecting the vessels of medium and large sizes. The incidence increases with age (the disease develops rarely before age 50) and the etiology remains unknown. Clinical manifestations may vary (including asthenia, temporal headache, visual disturbances, etc.) and GCA can potentially lead to dramatic consequences (permanent loss of vision). Although some anomalies in the investigations may help in the diagnosis of GCA, research and confirmation of the diagnosis of GCA may be difficult, especially when the symptoms presented by patients are spread out in time and appear to be nonspecific at first.
Assuntos
Arterite de Células Gigantes/diagnóstico , Prova Pericial , Feminino , Arterite de Células Gigantes/etiologia , Cefaleia/complicações , Humanos , Pessoa de Meia-IdadeRESUMO
The number of studies related to vitamin D has increased exponentially in recent years and it becomes difficult to integrate these data into daily practice. This article focuses on the practice by offering an overview on screening, needs, treatment and consequences of deficiency. While in some areas, a consensus seems to emerge, other issues still require a lot of research in order to have an impact on practice. Independently of the threshold values we use, there is an increased prevalence, which makes vitamin D deficiency the most common and also the most underdiagnosed deficiency. Vitamin D is like a marker of good health and a marker of the evolution of our society. How can be used this marker by the practitioner?
Assuntos
Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/uso terapêutico , Humanos , Guias de Prática Clínica como AssuntoRESUMO
In recent years many clinical prediction rules (CPR) have been developed. Before a CPR can be used in clinical practice, different methodical steps are necessary, from the development of the score, the internal and external validation to the impact study. Before using a CPR in daily practice family doctors have to verify how the rules have been developed and whether this has been done in a population similar to the population in which they would use them. The aim of this paper is to describe the development of a CPR, and to discuss advantages and risks related to the use of CPR in order to help family doctors in their choice of scores for use in their daily practice.
Assuntos
Técnicas de Apoio para a Decisão , Dor no Peito/etiologia , Medicina de Família e Comunidade , Cardiopatias/diagnóstico , Humanos , Modelos Logísticos , Reprodutibilidade dos TestesRESUMO
Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. IV iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last IV iron administration.
Assuntos
Deficiências de Ferro , Deficiências Nutricionais/diagnóstico , Deficiências Nutricionais/tratamento farmacológico , HumanosRESUMO
We know very little about the importance of history and physical examination compared to the importance of paraclinical tests in the diagnostic process in primary care. To answer this question, we examined prospectively 672 consecutive patients with chest pain in primary care. We recorded the timing and the clinical characteristics of the most frequent diagnosis. The resort to laboratory or other clinical tests and reference to specialist were influenced by: emergency consultation, potentially life-threatening aetiology, personal characteristics of the general practitioners' (GP) and patients' anxiety. GPs attributed the diagnosis to history and physical examination alone in 66% and to the association of history, physical examination and tests in 31% cases. This, clinical strategy remains the most important factor in the diagnostic process; even when they are insufficient, they allowed to generate hypotheses and guide investigations.
Assuntos
Dor no Peito/etiologia , Padrões de Prática Médica , Atenção Primária à Saúde , Instituições de Assistência Ambulatorial , Humanos , Estudos ProspectivosAssuntos
Testes de Aptidão , Exame para Habilitação de Motoristas , Condução de Veículo , Exame para Habilitação de Motoristas/legislação & jurisprudência , Condução de Veículo/legislação & jurisprudência , Condução de Veículo/psicologia , Cognição/efeitos dos fármacos , Cognição/fisiologia , Complicações do Diabetes/complicações , Complicações do Diabetes/fisiopatologia , Diabetes Mellitus/fisiopatologia , Diabetes Mellitus/psicologia , Distúrbios do Sono por Sonolência Excessiva/complicações , Distúrbios do Sono por Sonolência Excessiva/fisiopatologia , Distúrbios do Sono por Sonolência Excessiva/psicologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Destreza Motora/efeitos dos fármacos , Destreza Motora/fisiologia , Papel do Médico , Síndromes da Apneia do Sono/complicações , Síndromes da Apneia do Sono/fisiopatologia , Síndromes da Apneia do Sono/psicologiaRESUMO
This review is based on five articles published in 2006 and dealing with therapies in general internal medicine: in case of acute non complicated rhino-sinusitis, the use of topical corticoids in mono-therapy is indicated; cross-reactivity between penicillins and cephalosporins is less frequent than established so far. In our daily practice we should be more "pro-active" in prescribing probiotics which have proved their efficacy in the prevention of antibiotic-associated diarrhoeas; an antibiotic treatment of three days is recommended in case of non complicated cystitis in women less than 65 years of age. Finally, every patient treated with bisphosphonates must be regularly followed by a dentist.
Assuntos
Medicina Interna/métodos , HumanosRESUMO
BACKGROUND: While detoxification under anaesthesia accelerates the detoxification procedure, there is a lack of randomised clinical trials evaluating its effectiveness compared to traditional detoxification procedures, and a lack of data on long-term abstinence. METHODS: Prospective randomised clinical trial. Analysis by intention to treat and per protocol. SETTING: Specialised substance abuse unit in a psychiatric teaching hospital and an intensive care unit of a general hospital. PARTICIPANTS: Seventy patients with opiate mono-dependence requesting detoxification: 36 randomised to RODA (treatment as allocated received by 26) and 34 randomised to classical clonidine detoxification (treatment as allocated received by 21). MAIN OUTCOME MEASURES: Successful detoxification, safety and self-reported abstinence at 3, 6 and 12 months after detoxification. RESULTS: Socio-demographics were similar in both groups at baseline. No complications were reported during or after anaesthesia. According to the intention to treat analysis, 28/36 (78%) RODA patients and 21/34 (62%) of the clonidine group successfully completed the detoxification process (p=0.14). In the intention to treat analysis, 30% of RODA patients were abstinent after 3 months compared to 14% in the clonidine group (p=0.11). No difference was found at 6 and 12 months (both groups showed less than 5% abstinence after 12 months). The per-protocol analysis showed similar results with no statistical differences either for ASI mean scores or for the SF36 questionnaire. CONCLUSION: Although the detoxification success rate and abstinence after 3 months were slightly better for the RODA procedure compared to clonidine treatment, these differences were not statistically significant and disappeared completely after 6 and 12 months.
Assuntos
Analgésicos/uso terapêutico , Clonidina/uso terapêutico , Dependência de Heroína/tratamento farmacológico , Dependência de Heroína/psicologia , Inativação Metabólica , Naltrexona/uso terapêutico , Antagonistas de Entorpecentes/uso terapêutico , Síndrome de Abstinência a Substâncias/psicologia , Adulto , Algoritmos , Anestesia Geral , Esquema de Medicação , Feminino , Hospitais Psiquiátricos , Hospitais de Ensino , Humanos , Masculino , Estudos Prospectivos , Recidiva , Fatores de Tempo , Resultado do TratamentoRESUMO
BACKGROUND: Hypovitaminosis D is well known in different populations, but may be under diagnosed in certain populations. We aim to determine the first diagnosis considered, the duration and resolution of symptoms, and the predictors of response to treatment in female asylum seekers suffering from hypovitaminosis D. DESIGN: A pre- and post-intervention observational study. SETTING: A network comprising an academic primary care centre and nurse practitioners. PARTICIPANTS: Consecutive records of 33 female asylum seekers with complaints compatible with osteomalacia and with hypovitaminosis D (serum 25-(OH) vitamin D < 21 nmol/l). Treatment intervention: The patients received either two doses of 300,000 IU intramuscular cholecalciferol as well as 800 IU of cholecalciferol with 1000 mg of calcium orally, or the oral treatment only. MAIN OUTCOME MEASURES: We recorded the first diagnosis made by the physicians before the correct diagnosis of hypovitaminosis D, the duration of symptoms before diagnosis, the responders and non-responders to treatment, the duration of symptoms after treatment, and the number of medical visits and analgesic drugs prescribed 6 months before and 6 months after diagnosis. TESTS: Two-sample t-tests, chi-squared tests, and logistic regression analyses were performed. Analyses were performed using SPSS 10.0. RESULTS: Prior to the discovery of hypovitaminosis D, diagnoses related to somatisation were evoked in 30 patients (90.9%). The mean duration of symptoms before diagnosis was 2.53 years (SD 3.20). Twenty-two patients (66.7%) responded completely to treatment; the remaining patients were considered to be non-responders. After treatment was initiated, the responders' symptoms disappeared completely after 2.84 months. The mean number of emergency medical visits fell from 0.88 (SD 1.08) six months before diagnosis to 0.39 (SD 0.83) after (P = 0.027). The mean number of analgesic drugs that were prescribed also decreased from 1.67 (SD 1.5) to 0.85 (SD 1) (P = 0.001). CONCLUSION: Hypovitaminosis D in female asylum seekers may remain undiagnosed, with a prolonged duration of chronic symptoms. The potential pitfall is a diagnosis of somatisation. Treatment leads to a rapid resolution of symptoms, a reduction in the use of medical services, and the prescription of analgesic drugs in this vulnerable population.
Assuntos
Dor/etiologia , Deficiência de Vitamina D , 25-Hidroxivitamina D 2/sangue , Administração Oral , Adulto , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Cálcio/administração & dosagem , Cálcio/sangue , Cálcio/uso terapêutico , Distribuição de Qui-Quadrado , Colecalciferol/administração & dosagem , Colecalciferol/uso terapêutico , Prescrições de Medicamentos , Emergências , Feminino , Humanos , Injeções Intramusculares , Modelos Logísticos , Osteomalacia/diagnóstico , Dor/tratamento farmacológico , Atenção Primária à Saúde , Estudos Prospectivos , Radioimunoensaio , Espectrofotometria , Fatores de Tempo , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológicoRESUMO
Two retrospective epidemiologic studies have shown that cannabis is the main psychoactive substance detected in the blood of drivers suspected of driving under the influence of psychotropic drugs. An oral administration double-blind crossover study was carried out with eight healthy male subjects, aged 22 to 30 years, all occasional cannabis smokers. Three treatments and one placebo were administered to all participants at a two week interval: 20 mg dronabinol, 16.5 mg D9-tétrahydrocannabinol (THC) and 45.7 mg THC as a cannabis milk decoction. Participants were asked to report the subjective drug effects and their willingness to drive under various circumstances on a visual analog scale. Clinical observations, a psychomotor test and a tracking test on a driving simulator were also carried out. Compared to cannabis smoking, THC, 11-OH-THC and THC-COOH blood concentrations remained low through the whole study (<13.1 ng THC/mL,<24.7 ng 11-OH-THC/mL and<99.9 ng THC-COOH/mL). Two subjects experienced deep anxiety symptoms suggesting that this unwanted side-effect may occur when driving under the influence of cannabis or when driving and smoking a joint. No clear association could be found between these adverse reactions and a susceptibility gene to propensity to anxiety and psychotic symptoms (genetic polymorphism of the catechol-O-methyltransferase). The questionnaires have shown that the willingness to drive was lower when the drivers were assigned an insignificant task and was higher when the mission was of crucial importance. The subjects were aware of the effects of cannabis and their performances on the road sign and tracking test were greatly impaired, especially after ingestion of the strongest dose. The Cannabis Influence Factor (CIF) which relies on the molar ratio of active and inactive cannabinoids in blood provided a good estimate of the fitness to drive.
Assuntos
Condução de Veículo , Cannabis/efeitos adversos , Dronabinol/efeitos adversos , Alucinógenos/efeitos adversos , Adulto , Método Duplo-Cego , Humanos , Masculino , Desempenho Psicomotor/efeitos dos fármacosRESUMO
Internal carotid artery dissection typically manifests as an unilateral facial or latero-cervical pain, is often accompanied by an oculosympathetic palsy (myosis and palpebral ptosis) and may be followed by cerebral or retinal ischemia. Deficits of the IXth to XIIth cranial nerves or a pulsatile tinnitus have been described. These symptoms challenge our clinical skills and call for an early diagnosis in order to prevent ischemic complications. Both helical computed tomographic angiography and transcranial ultrasonography coupled with Doppler flow colour are excellent first-line imaging techniques. Conventional angiography has been replaced by magnetic resonance techniques as gold standard. In this article, we describe the case of a patient evaluated at our outpatient clinic and review briefly the literature on this topic.
Assuntos
Dor Facial/etiologia , Síndrome de Horner/complicações , Síndrome de Horner/diagnóstico , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
During the year 2005, the chief residents of the University Medical Outpatient Clinic of Lausanne have done a database of useful articles for daily practice, scientifically validated and with excellent didactic quality, from 10 electronic journals. They have used those selected articles in personal meetings between the chief residents on a regular basis and the possibility to access the database by the junior physicians. Six of these articles concerning different topics (depression, tuberculosis detection, anticoagulation at home, cholinesterase inhibitors, insomnia and therapies, transdermal nitroglycerin and tendinopathies) are presented.
Assuntos
Educação Médica Continuada/métodos , Medicina de Família e Comunidade/educação , Medicina Interna/educação , Publicações Periódicas como Assunto , Atenção Primária à Saúde , Administração Cutânea , Administração Oral , Doença de Alzheimer/tratamento farmacológico , Anticoagulantes/administração & dosagem , Inibidores da Colinesterase/uso terapêutico , Bases de Dados Bibliográficas , Depressão/diagnóstico , Humanos , Nitroglicerina/administração & dosagem , Distúrbios do Início e da Manutenção do Sono/etiologia , Distúrbios do Início e da Manutenção do Sono/terapia , Suíça , Tendinopatia/tratamento farmacológico , Tuberculose/diagnóstico , Vasodilatadores/administração & dosagemRESUMO
An open prospective study was conducted among the patients visiting an urban medical policlinic for the first time without an appointment to assess whether the immigrants (who represent more than half of our patients) are aware of the health effects of smoking, whether the level of acculturation influences knowledge, and whether doctors give similar advice to Swiss and foreign smokers. 226 smokers, 105 Swiss (46.5%), and 121 foreign-born (53.5%), participated in the study. 32.2% (95% CI [24.4%; 41.1%]) of migrants and 9.6% [5.3%; 16.8%] of Swiss patients were not aware of negative effects of smoking. After adjustment for age, the multivariate model showed that the estimated odds of "ignorance of health effects of smoking" was higher for people lacking mastery of the local language compared with those mastering it (odds ratio (OR) = 7.5 [3.6; 15.8], p < 0.001), and higher for men (OR = 4.3 [1.9; 10.0], p < 0.001). Advice to stop smoking was given with similar frequency to immigrants (31.9% [24.2%; 40.8%] and Swiss patients (29.0% [21.0%; 38.5%]). Nonintegrated patients did not appear to receive less counselling than integrated patients (OR = 1.1 [0.6; 2.1], p = 0.812). We conclude that the level of knowledge among male immigrants not integrated or unable to speak the local language is lower than among integrated foreign-born and Swiss patients. Smoking cessation counselling by a doctor was only given to a minority of patients, but such counselling seemed irrespective of nationality.